Search
The Deal magazine looks at the biotech sector and how new, creative funding deals are promising to rejuvenate the search for new drugs. Plus, this issue looks at LIBOR's new landscape. Meanwhile, we have an indepth conversation with CD&R's Joseph Rice.
June 18, 2012What goes up must come down, and so it would appear as The Deal magazine examines big-league bankruptcy. The theory holds for Tribune as it's new owners weigh its assets. But what about W.R. Grace, as it emerges from bankruptcy having made 22 acquisitions under protection? Plus, the corporate dealmaker 100.
May 28, 2012The Deal magazine takes an indepth look at the strategic dealmaking of the packaging industry in the middle market. We also hit the road looking at the startup landscape in the drug development and medical devices sectors in Kalamazoo, Michigan as well as the burgeoning companies in the solar power, pharmaceutical, brewery and pesticide industries in Bend, Oregon.
May 7, 2012Wanna do M&A? Careful, because here comes the shareholder litigation. When it comes to tech acquisitions, they're getting done -- just too bad companies aren't very good at it. And sovereign wealth funds are back, growing fast.
April 16, 2012No one said private equity would be easy, and our annual Private Equity Deals of the Year proves it again with a roundup of 2011's big winners and losers. Also, The Deal magazine takes a look at cowboy capitalism with a trip to Dallas-Fort Worth. Finally, take a look at our sampling of middle-market companies on the auction block.
April 2, 2012The Deal magazine travels to Japan to witness the island nation rise again amidst an active streak of dealmaking. Plus, a duet of music-related articles look at the antitrust snares of Universal Music's purchase of EMI assets and the effect that the emergence of digital music is having on copyright laws.
March 12, 2012In this issue, The Deal magazine hits the bankruptcy trifecta: the take-no-prisoners battle for Alter Communications; the rise and fall of real estate moguls, the Meruelo brothers; and the bankruptcy league tables. Also, take a look at how Humana has set a new course along the acquisition trail.
February 20, 2012The Deal magazine focuses on the middle market by looking at some of its top dealmakers and then gives an overview of what's out there on the auction block. The issue also features an in-depth look at private equity in France and in emerging markets around the world.
February 6, 2012The Deal magazine gets in the pilot seat to take a look at American Airlines' bankruptcy, then wonders what will now happen to a beleaguered Reader's Digest. Also, Herb Fritch of HealthSpring may have an answer to the sky-high inflation of the healthcare industry.
January 23, 2011What a topsy-turvy, rumbly-tumbly year 2011 turned out to be -- and The Deal magazine takes a look at the M&A Deals of the Year in uncertain times. Also, Edgar Bronfman Jr. sits down for his first interview since selling Warner Music.
December 12, 2011Just when you thought it was safe to go back in the water, suddenly it was 2011 -- and The Deal magazine looks back at all the twists and turns of dealmaking. Also in this issue, dealmakers pay back as social entrepreneurs.
November 28, 2011'What worrying wall of debt?' The Deal magazine asks. Oh, right, there it is. Plus, the Windy City offers up its own particular brand of private equity, while, farther afield, Big Oil makes a play in Kurdistan.
November 14, 2011The Deal magazine tracks down the in-house corporate dealmakers from the top American companies and takes a voyage around the world to explore the valleys and peaks of the travel industry.
October 31, 2011The Deal magazine goes back to school and offers a full report on the business of education.
October 17, 2011The Deal magazine goes looking for trolls and geeks, and the middle market shows its ups and downs in a trying economy.
October 3, 2011Who are the private equity movers and shakers to keep an eye on, and how does Ralph de la Torre look to transform managed care?
September 19, 2011The Deal magazine honors this year's Most Admired Corporate Dealmakers and takes a close look at the ups and downs of Wall Street compensation.
September 5, 2011The interview issue asks all the pertinent questions to six experts in their respective fields, while the market for multiple sclerosis therapies provides an evocative case study on dealmaking.
July 25, 2011The Deal magazine gets up close and personal with faces of the middle market and charts the new hits of the music business as it shifts away from label dominance.
June 27, 2011Despite trying financial times, the spotlight shines on the private equity deals of the year that were deftly executed and held to the principle of creating value.
PwC partner Timothy Hartnett chats with The Deal Pipeline about Brazil's staying power in the private equity universe.
Sullivan & Cromwell's Frank Aquila shares what he thinks are the leading drivers for current M&A deals.
Since the '70s, private equity and the midmarket have developed a symbiosis that can't be denied. The ties have a lot to do with the challenges of globalization in a tech-centric age.
Morgan Joseph moves forward after the death of the firm's influential founder Fred Joseph.
After buying McGladrey, the firm is well positioned to hit the acquisition trail in search of middle-market banks and boutiques that can 'deepen the industries we're in.'
U.S. companies have been slow to buy in the Middle Kingdom, but some say that's about to change.
A deal with Intel that includes 190 patents and 170 patent applications will net Nielsen's company $120 million.
An avoidable row over the compensation of the Royal Bank CEO has left him, the bank's board and Prime Minister Cameron diminished and humiliated.
New hires at both Kirkland and Dewey & LeBouef pay off, and Apache remains faithful to Goldman.
With a reported net worth greater than $200 million, the private equity titan and soccer mogul favored a more progressive tax system.
The chief development officer and general counsel discusses valuing media properties, magazines and the Web, and the middle market.
After riding a wave of spinouts, the CEO of the chipmaker discusses his company's first acquisition, Picochip.
Regions sells Morgan Keegan, Goldner Hawn unloads Remmele, Angiodynamics wins Navilyst, and Gennum completes its restructuring.
Mostly hirings, some firings, defections, new offices, retirements and fond remembrances when appropriate.
It's no longer the exclusive fiefdom of the global firms. Increasingly, indigenous funds are raising and investing capital. Their names may be unfamiliar, but not for long.
Top buyout shops in the country such as Champ Private Equity place much importance on Asia.
Private equity firm Ethos has made over a hundred investments in an economy where, unlike most other emerging markets, it has access to debt.
There are just three firms that constitute Turkey's indigenous private equity industry, and their combined funds under management total less than $1.4 billion.
The South American nation's homegrown buyout shops have made more inroads in the country than the international counterparts.
Once private equity in the Gallic nation mirrored the ups and downs of the industry's American pioneers. But today the markets are heading in different directions. Here's why.
Despite early opposition, both Carlyle and Colony have found places for themselves in the French economy.
CEO Lionel Zinsou took the helm at a time the company was perceived as arrogant, and then cashed in on Europe's capital markets revival in 2010 and 2011.
Every year, thousands of middle-market companies go up for sale. Here's a sampling.
Marc Zuckerberg, Facebook and the public-private dilemma.
Every time the market swoons and Wall Street reels, the doomsayers and soul searchers declare the joint dead. Watch for the bounce.
The Harvard Law professor takes on the topics in 'Managing Disputes Through Contract' and 'Hiring Teams, Firms and Lawyers,' respectively.
The U.S.'s neighbor to the north has made a number of moves within its Competition Bureau to stamp out anticompetitive behavior.
Despite fiscal woes in the U.S., infrastructure funds remain upbeat about public-private partnerships.
If operational issues are not targeted, conscientious due diligence may not reveal the pitfalls and opportunities an investor faces when buying a manufacturer.
Midmarket buyout investing is particularly interesting for a number of reasons, including attractive acquisition multiples and reduced competition for smaller nonauctioned businesses.
There is a structural solution that will ensure higher equity levels and greater stability to prevent future banking system failures.
